28373195|t|Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens
28373195|a|mcr-1 was initially reported as the first plasmid -mediated colistin resistance gene in clinical isolates of Escherichia coli and Klebsiella pneumoniae in China and has subsequently been identified worldwide in various species of the family Enterobacteriaceae mcr-1 encodes a phosphoethanolamine transferase, and its expression has been shown to generate phosphoethanolamine -modified bis-phosphorylated hexa-acylated lipid A in E. coli Here, we investigated the effects of mcr-1 on colistin susceptibility and on lipopolysaccharide structures in laboratory and clinical strains of the Gram-negative ESKAPE (Enterococcus faecium, Staphylococcus aureus, K. pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens, which are often treated clinically by colistin. The effects of mcr-1 on colistin resistance were determined using MIC assays of laboratory and clinical strains of E. coli, K. pneumoniae, A. baumannii, and P. aeruginosa Lipid A structural changes resulting from MCR-1 were analyzed by mass spectrometry. The introduction of mcr-1 led to colistin resistance in E. coli, K. pneumoniae, and A. baumannii but only moderately reduced susceptibility in P. aeruginosa Phosphoethanolamine modification of lipid A was observed consistently for all four species. These findings highlight the risk of colistin resistance as a consequence of mcr-1 expression among ESKAPE pathogens, especially in K. pneumoniae and A. baumannii Furthermore, the observation that lipid A structures were modified despite only modest increases in colistin MICs in some instances suggests more sophisticated surveillance methods may need to be developed to track the dissemination of mcr-1 or plasmid -mediated phosphoethanolamine transferases in general.
28373195	0	23	Structural Modification	T058	UMLS:C0581602
28373195	27	45	Lipopolysaccharide	T103	UMLS:C0023810
28373195	59	64	mcr-1	T017	UMLS:C0017337
28373195	68	88	Gram-Negative ESKAPE	T007	UMLS:C0018150
28373195	99	104	mcr-1	T017	UMLS:C0017337
28373195	141	148	plasmid	T103	UMLS:C0032136
28373195	159	167	colistin	T103	UMLS:C0009316
28373195	187	204	clinical isolates	T103	UMLS:C1764827
28373195	208	224	Escherichia coli	T007	UMLS:C0014834
28373195	229	250	Klebsiella pneumoniae	T007	UMLS:C0001699
28373195	254	259	China	T082	UMLS:C0008115
28373195	318	325	species	T170	UMLS:C1705920
28373195	333	358	family Enterobacteriaceae	T007	UMLS:C0014346
28373195	359	364	mcr-1	T017	UMLS:C0017337
28373195	375	406	phosphoethanolamine transferase	T038	UMLS:C2248757
28373195	416	426	expression	T038	UMLS:C0017262
28373195	454	473	phosphoethanolamine	T103	UMLS:C0070939
28373195	484	524	bis-phosphorylated hexa-acylated lipid A	T103	UMLS:C0023767
28373195	528	535	E. coli	T007	UMLS:C0014834
28373195	573	578	mcr-1	T017	UMLS:C0017337
28373195	582	590	colistin	T103	UMLS:C0009316
28373195	591	605	susceptibility	T033	UMLS:C0427965
28373195	613	631	lipopolysaccharide	T103	UMLS:C0023810
28373195	632	642	structures	T082	UMLS:C0678594
28373195	646	656	laboratory	T092	UMLS:C0022877
28373195	685	705	Gram-negative ESKAPE	T007	UMLS:C0018150
28373195	707	727	Enterococcus faecium	T007	UMLS:C0085495
28373195	729	750	Staphylococcus aureus	T007	UMLS:C0038172
28373195	752	765	K. pneumoniae	T007	UMLS:C0001699
28373195	752	765	K. pneumoniae	T007	UMLS:C0001699
28373195	767	790	Acinetobacter baumannii	T007	UMLS:C0314787
28373195	792	814	Pseudomonas aeruginosa	T007	UMLS:C0033809
28373195	820	840	Enterobacter species	T007	UMLS:C1295792
28373195	891	899	colistin	T103	UMLS:C0009316
28373195	916	921	mcr-1	T017	UMLS:C0017337
28373195	925	933	colistin	T103	UMLS:C0009316
28373195	967	977	MIC assays	T058	UMLS:C0427978
28373195	981	991	laboratory	T092	UMLS:C0022877
28373195	1016	1023	E. coli	T007	UMLS:C0014834
28373195	1025	1038	K. pneumoniae	T007	UMLS:C0001699
28373195	1040	1052	A. baumannii	T007	UMLS:C0314787
28373195	1058	1071	P. aeruginosa	T007	UMLS:C0033809
28373195	1072	1079	Lipid A	T103	UMLS:C0023767
28373195	1080	1090	structural	T082	UMLS:C0678594
28373195	1114	1119	MCR-1	T103	UMLS:C4308704
28373195	1137	1154	mass spectrometry	T058	UMLS:C0037813
28373195	1176	1181	mcr-1	T017	UMLS:C0017337
28373195	1189	1197	colistin	T103	UMLS:C0009316
28373195	1212	1219	E. coli	T007	UMLS:C0014834
28373195	1221	1234	K. pneumoniae	T007	UMLS:C0001699
28373195	1240	1252	A. baumannii	T007	UMLS:C0314787
28373195	1281	1295	susceptibility	T033	UMLS:C0427965
28373195	1299	1312	P. aeruginosa	T007	UMLS:C0033809
28373195	1313	1332	Phosphoethanolamine	T103	UMLS:C0070939
28373195	1333	1345	modification	T033	UMLS:C3840684
28373195	1349	1356	lipid A	T103	UMLS:C0023767
28373195	1396	1403	species	T170	UMLS:C1705920
28373195	1442	1450	colistin	T103	UMLS:C0009316
28373195	1482	1487	mcr-1	T017	UMLS:C0017337
28373195	1488	1498	expression	T038	UMLS:C0017262
28373195	1505	1511	ESKAPE	T007	UMLS:C0018150
28373195	1537	1550	K. pneumoniae	T007	UMLS:C0001699
28373195	1555	1567	A. baumannii	T007	UMLS:C0314787
28373195	1602	1609	lipid A	T103	UMLS:C0023767
28373195	1610	1620	structures	T082	UMLS:C0678594
28373195	1668	1676	colistin	T103	UMLS:C0009316
28373195	1677	1681	MICs	T058	UMLS:C0427978
28373195	1728	1748	surveillance methods	T062	UMLS:C1515093
28373195	1787	1800	dissemination	T082	UMLS:C0205221
28373195	1804	1809	mcr-1	T017	UMLS:C0017337
28373195	1813	1820	plasmid	T103	UMLS:C0032136
28373195	1813	1820	plasmid	T103	UMLS:C0032136
28373195	1831	1863	phosphoethanolamine transferases	T038	UMLS:C2248757